Ronald M. Kurtz MD - 10 Feb 2023 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
President & CEO, Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
10 Feb 2023
Net transactions value
+$500,000
Form type
4
Filing time
13 Feb 2023, 17:19:14 UTC
Previous filing
05 Aug 2021
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Award $500,000 +40,000 $12.50 40,000 10 Feb 2023 Direct
holding RXST Common Stock 929,610 10 Feb 2023 See footnore F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 125,000 shares reported as directly held by the Reporting Person in previous Form 4 filings.
F2 Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.

Remarks:

President & Chief Executive Officer